Fling for Logan challenges
Raising funds and awareness of Duchenne Muscular Dystrophy for my son Logan
flingforlogan.com
Monday, 25 July 2011
AVI BioPharma - News Release
AVI BioPharma - News Release
: "The Lancet Publishes Clinical Trial Data That Demonstrate Statistically Significant and Dose-Dependent Expression of Dystrophin in Duchenne Muscular Dystrophy Patients Treated With AVI BioPharma's Eteplirsen"
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment